10-Q Filing

MCKESSON CORP CIK: 927653 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0000927653-17-000018`
Period End Date	20170930
Filing Date	20171027
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	mck-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 106 Cash Flow Statement 80 Comprehensive Income 36

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.05B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.56B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.78B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.46B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$18.21B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$19.63B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories, net	`InventoryNet`	$15.28B	USD	Point-in-time
Inventories, net	`InventoryNet`	$16.89B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$719.00M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$672.00M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$36.95B	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$39.79B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	274.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	273.00M	shares	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$2.29B	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$2.35B	USD	Point-in-time
Goodwill	`Goodwill`	$11.73B	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	62.00M	shares	Point-in-time
Goodwill	`Goodwill`	$10.59B	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	66.00M	shares	Point-in-time
Intangible Assets, Net	`FiniteLivedIntangibleAssetsNet`	$4.21B	USD	Point-in-time
Intangible Assets, Net	`FiniteLivedIntangibleAssetsNet`	$3.67B	USD	Point-in-time
Equity Method Investment in Change Healthcare	`EquityMethodInvestments`	$4.06B	USD	Point-in-time
Equity Method Investment in Change Healthcare	`EquityMethodInvestments`	$3.79B	USD	Point-in-time
Other Noncurrent Assets	`OtherAssetsNoncurrent`	$3.42B	USD	Point-in-time
Other Noncurrent Assets	`OtherAssetsNoncurrent`	$1.97B	USD	Point-in-time
Total Assets	`Assets`	$63.85B	USD	Point-in-time
Total Assets	`Assets`	$60.97B	USD	Point-in-time
Drafts and accounts payable	`AccountsPayableCurrent`	$31.02B	USD	Point-in-time
Drafts and accounts payable	`AccountsPayableCurrent`	$33.58B	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$306.00M	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$183.00M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$346.00M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$63.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.06B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$525.00M	USD	Point-in-time
Other accrued liabilities	`AccruedLiabilitiesCurrent`	$3.29B	USD	Point-in-time
Other accrued liabilities	`AccruedLiabilitiesCurrent`	$3.00B	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$37.77B	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$35.61B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$7.49B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$7.30B	USD	Point-in-time
Long-Term Deferred Tax Liabilities	`DeferredIncomeTaxLiabilitiesNet`	$3.68B	USD	Point-in-time
Long-Term Deferred Tax Liabilities	`DeferredIncomeTaxLiabilitiesNet`	$3.72B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$1.77B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$2.08B	USD	Point-in-time
Redeemable Noncontrolling Interests	`RedeemableNoncontrollingInterestEquityCommonCarryingAmount`	$1.42B	USD	Point-in-time
Redeemable Noncontrolling Interests	`RedeemableNoncontrollingInterestEquityCommonCarryingAmount`	$1.33B	USD	Point-in-time
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value, 800 shares authorized at September 30, 2017 and March 31, 2017, 274 and 273 shares issued at September 30, 2017 and March 31, 2017	`CommonStockValue`	$3.00M	USD	Point-in-time
Common stock, $0.01 par value, 800 shares authorized at September 30, 2017 and March 31, 2017, 274 and 273 shares issued at September 30, 2017 and March 31, 2017	`CommonStockValue`	$3.00M	USD	Point-in-time
Additional Paid-in Capital	`AdditionalPaidInCapital`	$6.03B	USD	Point-in-time
Additional Paid-in Capital	`AdditionalPaidInCapital`	$6.14B	USD	Point-in-time
Retained Earnings	`RetainedEarningsAccumulatedDeficit`	$13.37B	USD	Point-in-time
Retained Earnings	`RetainedEarningsAccumulatedDeficit`	$13.19B	USD	Point-in-time
Accumulated Other Comprehensive Loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.71B	USD	Point-in-time
Accumulated Other Comprehensive Loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.14B	USD	Point-in-time
Other	`OtherCapital`	$2.00M	USD	Point-in-time
Other	`OtherCapital`	$3.00M	USD	Point-in-time
Treasury Shares, at Cost, 66 and 62 at September 30, 2017 and March 31, 2017	`TreasuryStockValue`	$6.66B	USD	Point-in-time
Treasury Shares, at Cost, 66 and 62 at September 30, 2017 and March 31, 2017	`TreasuryStockValue`	$5.98B	USD	Point-in-time
Total McKesson Corporation Stockholders Equity	`StockholdersEquity`	$11.14B	USD	Point-in-time
Total McKesson Corporation Stockholders Equity	`StockholdersEquity`	$11.10B	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$219.00M	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$178.00M	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.27B	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.36B	USD	Point-in-time
Total Liabilities, Redeemable Noncontrolling Interests and Equity	`LiabilitiesAndStockholdersEquity`	$63.85B	USD	Point-in-time
Total Liabilities, Redeemable Noncontrolling Interests and Equity	`LiabilitiesAndStockholdersEquity`	$60.97B	USD	Point-in-time

Income Statement 106 line items

Line Item	Tag	Value	Unit	Period
Revenues	`SalesRevenueNet`	$49.96B	USD	1 Quarter
Revenues	`SalesRevenueNet`	$52.06B	USD	1 Quarter
Revenues	`SalesRevenueNet`	$99.69B	USD	2 Qtrs
Revenues	`SalesRevenueNet`	$103.11B	USD	2 Qtrs
Cost of Sales	`CostOfRevenue`	$49.23B	USD	1 Quarter
Cost of Sales	`CostOfRevenue`	$97.72B	USD	2 Qtrs
Cost of Sales	`CostOfRevenue`	$47.20B	USD	1 Quarter
Cost of Sales	`CostOfRevenue`	$94.03B	USD	2 Qtrs
Gross Profit	`GrossProfit`	$5.39B	USD	2 Qtrs
Gross Profit	`GrossProfit`	$5.66B	USD	2 Qtrs
Gross Profit	`GrossProfit`	$2.76B	USD	1 Quarter
Gross Profit	`GrossProfit`	$2.83B	USD	1 Quarter
Operating Expenses	`OperatingExpenses`	$1.89B	USD	1 Quarter
Operating Expenses	`OperatingExpenses`	$3.94B	USD	2 Qtrs
Operating Expenses	`OperatingExpenses`	$2.01B	USD	1 Quarter
Operating Expenses	`OperatingExpenses`	$3.82B	USD	2 Qtrs
Goodwill Impairment Charges	`GoodwillImpairmentLoss`	$350.00M	USD	1 Quarter
Goodwill Impairment Charges	`GoodwillImpairmentLoss`	$350.00M	USD	2 Qtrs
Goodwill Impairment Charges	`GoodwillImpairmentLoss`	$290.00M	USD	2 Qtrs
Goodwill Impairment Charges	`GoodwillImpairmentLoss`	$290.00M	USD	1 Quarter
Restructuring and Asset Impairment Charges	`RestructuringCharges`	-	USD	2 Qtrs
Restructuring and Asset Impairment Charges	`RestructuringCharges`	$236.00M	USD	1 Quarter
Restructuring and Asset Impairment Charges	`RestructuringCharges`	$236.00M	USD	2 Qtrs
Restructuring and Asset Impairment Charges	`RestructuringCharges`	-	USD	1 Quarter
Operating Income	`OperatingIncomeLoss`	$872.00M	USD	2 Qtrs
Operating Income	`OperatingIncomeLoss`	$1.55B	USD	2 Qtrs
Operating Income	`OperatingIncomeLoss`	$580.00M	USD	1 Quarter
Operating Income	`OperatingIncomeLoss`	$239.00M	USD	1 Quarter
Other Income, Net	`OtherNonoperatingIncomeExpense`	$82.00M	USD	2 Qtrs
Other Income, Net	`OtherNonoperatingIncomeExpense`	$69.00M	USD	1 Quarter
Other Income, Net	`OtherNonoperatingIncomeExpense`	$42.00M	USD	2 Qtrs
Other Income, Net	`OtherNonoperatingIncomeExpense`	$23.00M	USD	1 Quarter
Loss from Equity Method Investment in Change Healthcare	`IncomeLossFromEquityMethodInvestments`	-	USD	2 Qtrs
Loss from Equity Method Investment in Change Healthcare	`IncomeLossFromEquityMethodInvestments`	$-61.00M	USD	1 Quarter
Loss from Equity Method Investment in Change Healthcare	`IncomeLossFromEquityMethodInvestments`	-	USD	1 Quarter
Loss from Equity Method Investment in Change Healthcare	`IncomeLossFromEquityMethodInvestments`	$-181.00M	USD	2 Qtrs
Interest Expense	`InterestAndDebtExpense`	$137.00M	USD	2 Qtrs
Interest Expense	`InterestAndDebtExpense`	$78.00M	USD	1 Quarter
Interest Expense	`InterestAndDebtExpense`	$157.00M	USD	2 Qtrs
Interest Expense	`InterestAndDebtExpense`	$69.00M	USD	1 Quarter
Income from Continuing Operations Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.44B	USD	2 Qtrs
Income from Continuing Operations Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$636.00M	USD	2 Qtrs
Income from Continuing Operations Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$178.00M	USD	1 Quarter
Income from Continuing Operations Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$525.00M	USD	1 Quarter
Income Tax Expense	`IncomeTaxExpenseBenefit`	$217.00M	USD	2 Qtrs
Income Tax Expense	`IncomeTaxExpenseBenefit`	$200.00M	USD	1 Quarter
Income Tax Expense	`IncomeTaxExpenseBenefit`	$439.00M	USD	2 Qtrs
Income Tax Expense	`IncomeTaxExpenseBenefit`	$122.00M	USD	1 Quarter
Income from Continuing Operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$325.00M	USD	1 Quarter
Income from Continuing Operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$56.00M	USD	1 Quarter
Income from Continuing Operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$998.00M	USD	2 Qtrs
Income from Continuing Operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$419.00M	USD	2 Qtrs
Income (Loss) from Discontinued Operations, Net of Tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Income (Loss) from Discontinued Operations, Net of Tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-114.00M	USD	2 Qtrs
Income (Loss) from Discontinued Operations, Net of Tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$2.00M	USD	2 Qtrs
Income (Loss) from Discontinued Operations, Net of Tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	1 Quarter
Net Income	`ProfitLoss`	$56.00M	USD	1 Quarter
Net Income	`ProfitLoss`	$324.00M	USD	1 Quarter
Net Income	`ProfitLoss`	$421.00M	USD	2 Qtrs
Net Income	`ProfitLoss`	$884.00M	USD	2 Qtrs
Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$111.00M	USD	2 Qtrs
Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$35.00M	USD	2 Qtrs
Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$55.00M	USD	1 Quarter
Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$17.00M	USD	1 Quarter
Net Income Attributable to McKesson Corporation	`NetIncomeLoss`	$1.00M	USD	1 Quarter
Net Income Attributable to McKesson Corporation	`NetIncomeLoss`	$310.00M	USD	2 Qtrs
Net Income Attributable to McKesson Corporation	`NetIncomeLoss`	$307.00M	USD	1 Quarter
Net Income Attributable to McKesson Corporation	`NetIncomeLoss`	$849.00M	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$4.22	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.01	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.46	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.35	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.50	USD	2 Qtrs
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.01	USD	2 Qtrs
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	1 Quarter
Total (in dollars per share)	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Total (in dollars per share)	`EarningsPerShareDiluted`	$1.47	USD	2 Qtrs
Total (in dollars per share)	`EarningsPerShareDiluted`	$1.34	USD	1 Quarter
Total (in dollars per share)	`EarningsPerShareDiluted`	$3.72	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.47	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$4.27	USD	2 Qtrs
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.01	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.36	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.01	USD	2 Qtrs
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.51	USD	2 Qtrs
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Total (in dollars per share)	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Total (in dollars per share)	`EarningsPerShareBasic`	$1.36	USD	1 Quarter
Total (in dollars per share)	`EarningsPerShareBasic`	$1.48	USD	2 Qtrs
Total (in dollars per share)	`EarningsPerShareBasic`	$3.76	USD	2 Qtrs
Dividends declared per common share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.34	USD	1 Quarter
Dividends declared per common share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.62	USD	2 Qtrs
Dividends declared per common share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.34	USD	Point-in-time
Dividends declared per common share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.56	USD	2 Qtrs
Dividends declared per common share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.28	USD	1 Quarter
Dividends declared per common share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.28	USD	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	228.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	228.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	211.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	210.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	210.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	209.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	226.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	226.00M	shares	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$56.00M	USD	1 Quarter
Net income	`ProfitLoss`	$324.00M	USD	1 Quarter
Net income	`ProfitLoss`	$421.00M	USD	2 Qtrs
Net income	`ProfitLoss`	$884.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$463.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$459.00M	USD	2 Qtrs
Goodwill impairment and other asset impairment charges	`GoodwillAndIntangibleAssetImpairment`	$290.00M	USD	2 Qtrs
Goodwill impairment and other asset impairment charges	`GoodwillAndIntangibleAssetImpairment`	$539.00M	USD	2 Qtrs
Loss from equity method investment in Change Healthcare	`IncomeLossFromEquityMethodInvestments`	-	USD	2 Qtrs
Loss from equity method investment in Change Healthcare	`IncomeLossFromEquityMethodInvestments`	$-61.00M	USD	1 Quarter
Loss from equity method investment in Change Healthcare	`IncomeLossFromEquityMethodInvestments`	-	USD	1 Quarter
Loss from equity method investment in Change Healthcare	`IncomeLossFromEquityMethodInvestments`	$-181.00M	USD	2 Qtrs
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-42.00M	USD	2 Qtrs
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$90.00M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$57.00M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$79.00M	USD	2 Qtrs
Charges (credits) associated with last-in-first-out inventory method	`InventoryLIFOReservePeriodCharge`	$-3.00M	USD	2 Qtrs
Charges (credits) associated with last-in-first-out inventory method	`InventoryLIFOReservePeriodCharge`	$4.00M	USD	2 Qtrs
Loss (gain) from sale of businesses and equity investments	`GainLossOnDispositionOfAssets1`	$47.00M	USD	2 Qtrs
Loss (gain) from sale of businesses and equity investments	`GainLossOnDispositionOfAssets1`	$-113.00M	USD	2 Qtrs
Other non-cash items	`OtherNoncashIncomeExpense`	$28.00M	USD	2 Qtrs
Other non-cash items	`OtherNoncashIncomeExpense`	$-5.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$812.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$657.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$1.22B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-162.00M	USD	2 Qtrs
Drafts and accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.81B	USD	2 Qtrs
Drafts and accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.17B	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-254.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-138.00M	USD	2 Qtrs
Taxes	`IncreaseDecreaseInAccruedTaxesPayable`	$86.00M	USD	2 Qtrs
Taxes	`IncreaseDecreaseInAccruedTaxesPayable`	$151.00M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$390.00M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$13.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.93B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.34B	USD	2 Qtrs
Payments for property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$151.00M	USD	2 Qtrs
Payments for property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$164.00M	USD	2 Qtrs
Capitalized software expenditures	`PaymentsToAcquireSoftware`	$89.00M	USD	2 Qtrs
Capitalized software expenditures	`PaymentsToAcquireSoftware`	$91.00M	USD	2 Qtrs
Acquisitions, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.87B	USD	2 Qtrs
Acquisitions, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$2.04B	USD	2 Qtrs
Proceeds from/ (payments for) sale of businesses and equity investments, net	`CashDivestedFromDeconsolidation`	$98.00M	USD	2 Qtrs
Proceeds from/ (payments for) sale of businesses and equity investments, net	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$164.00M	USD	2 Qtrs
Payments received on Healthcare Technology Net Asset Exchange	`ProceedsFromDivestitureOfBusinesses`	$126.00M	USD	2 Qtrs
Payments received on Healthcare Technology Net Asset Exchange	`ProceedsFromDivestitureOfBusinesses`	-	USD	2 Qtrs
Restricted cash for acquisitions	`IncreaseDecreaseInRestrictedCash`	$-935.00M	USD	2 Qtrs
Restricted cash for acquisitions	`IncreaseDecreaseInRestrictedCash`	$-1.47B	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$26.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-98.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.35B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-396.00M	USD	2 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$10.00M	USD	2 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$8.46B	USD	2 Qtrs
Repayments of short-term borrowings	`RepaymentsOfShortTermDebt`	$8.34B	USD	2 Qtrs
Repayments of short-term borrowings	`RepaymentsOfShortTermDebt`	$17.00M	USD	2 Qtrs
Repayments of long-term debt	`ProceedsFromRepaymentsOfDebt`	$-6.00M	USD	2 Qtrs
Repayments of long-term debt	`ProceedsFromRepaymentsOfDebt`	$-545.00M	USD	2 Qtrs
Issuances	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$75.00M	USD	2 Qtrs
Issuances	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$83.00M	USD	2 Qtrs
Share repurchases, including shares surrendered for tax withholding	`PaymentsForRepurchaseOfCommonStock`	$701.00M	USD	2 Qtrs
Share repurchases, including shares surrendered for tax withholding	`PaymentsForRepurchaseOfCommonStock`	$58.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividendsCommonStock`	$121.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividendsCommonStock`	$129.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$11.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-109.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27B	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-114.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$109.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-52.00M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.42B	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-220.00M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.05B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.56B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.78B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.46B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.05B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.56B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.78B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.46B	USD	Point-in-time

Comprehensive Income 36 line items

Line Item	Tag	Value	Unit	Period
Net Income	`ProfitLoss`	$56.00M	USD	1 Quarter
Net Income	`ProfitLoss`	$324.00M	USD	1 Quarter
Net Income	`ProfitLoss`	$421.00M	USD	2 Qtrs
Net Income	`ProfitLoss`	$884.00M	USD	2 Qtrs
Foreign currency translation adjustments arising during the period	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$303.00M	USD	1 Quarter
Foreign currency translation adjustments arising during the period	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$685.00M	USD	2 Qtrs
Foreign currency translation adjustments arising during the period	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-109.00M	USD	1 Quarter
Foreign currency translation adjustments arising during the period	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-364.00M	USD	2 Qtrs
Unrealized losses on net investment hedges arising during the period	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-108.00M	USD	2 Qtrs
Unrealized losses on net investment hedges arising during the period	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-38.00M	USD	1 Quarter
Unrealized losses on net investment hedges arising during the period	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	-	USD	1 Quarter
Unrealized losses on net investment hedges arising during the period	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	-	USD	2 Qtrs
Unrealized gains (losses) on cash flow hedges arising during the period	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-6.00M	USD	1 Quarter
Unrealized gains (losses) on cash flow hedges arising during the period	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-6.00M	USD	2 Qtrs
Unrealized gains (losses) on cash flow hedges arising during the period	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$11.00M	USD	2 Qtrs
Unrealized gains (losses) on cash flow hedges arising during the period	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-3.00M	USD	1 Quarter
Retirement-related benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$3.00M	USD	1 Quarter
Retirement-related benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Retirement-related benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-12.00M	USD	2 Qtrs
Retirement-related benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$8.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-114.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$580.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-358.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$259.00M	USD	1 Quarter
Comprehensive Income (Loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$526.00M	USD	2 Qtrs
Comprehensive Income (Loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$315.00M	USD	1 Quarter
Comprehensive Income (Loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$210.00M	USD	1 Quarter
Comprehensive Income (Loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	2 Qtrs
Comprehensive Loss (Income) Attributable to Noncontrolling Interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$88.00M	USD	1 Quarter
Comprehensive Loss (Income) Attributable to Noncontrolling Interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-30.00M	USD	2 Qtrs
Comprehensive Loss (Income) Attributable to Noncontrolling Interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$18.00M	USD	1 Quarter
Comprehensive Loss (Income) Attributable to Noncontrolling Interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$260.00M	USD	2 Qtrs
Comprehensive Income (Loss) Attributable to McKesson Corporation	`ComprehensiveIncomeNetOfTax`	$556.00M	USD	2 Qtrs
Comprehensive Income (Loss) Attributable to McKesson Corporation	`ComprehensiveIncomeNetOfTax`	$741.00M	USD	2 Qtrs
Comprehensive Income (Loss) Attributable to McKesson Corporation	`ComprehensiveIncomeNetOfTax`	$227.00M	USD	1 Quarter
Comprehensive Income (Loss) Attributable to McKesson Corporation	`ComprehensiveIncomeNetOfTax`	$192.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.